The antitumor function of these cells is ambiguous, where most studies indicate that type II NKT-cells support tumor immunosurveillance by secreting IL13 (Terabe et al., 2003; Ambrosino et al., 2007; Fichtner-Feigl et al., 2008). Here, IL13 is linked to neoplasm.